What is it about?
A recent progress on epigenetic drugs that could possibly be used against the most common malignant tumors of childhood, such as medulloblastomas, high-grade gliomas and ependymomas.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
Advanced epigenetic drugs target specific epigenetic alterations of the brain tumor molecular profile.
Read the Original
This page is a summary of: Advances on Epigenetic Drugs for Pediatric Brain Tumors, Current Neuropharmacology, July 2023, Bentham Science Publishers,
DOI: 10.2174/1570159x20666220922150456.
You can read the full text:
Contributors
The following have contributed to this page
